Vijay G Nair

This inventor holds 21 USPTO granted patents, primarily in Glycoscience Innovations. Top assignee: American Cyanamid Company. Active years: 1977-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vijay G Nair. Retrieved from https://idiyas.com/inventor/vijay-g-nair

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21

% Patents Active = 100.0

Average Co-Inventor Count = 2.6

ph-index = 7

Forward Citations = 215(Granted Patents)

Location History:

Piermont, NY (US) (1982)
New York, NY (US) (1980 - 1983)
Nanuet, NY (US) (1977 - 1990)

Company Filing History:

21 out of 3,580

American Cyanamid Company

patents

Years Active: 1977-1990

Loading Chart...

Areas of Expertise:

Glycoscience

Rutin Poly(H-)Sulfate

Complement Inhibitors

Oligosaccharides

Dibenzothiophenes

Carbalkoxymethyl Derivatives

Galactopyranosyl Compounds

Cyclodextrin Sulfates

Malto-Dextrin

Polygalactosido-Sucrose

Adamantylcarbonyl

Hydroxyalkyl Ethers

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4965284 - Substituted dibenzothiophenes (1990-10-23),

2. 4414207 - Rutin poly(H-)sulfate salts and related compounds (1983-11-08),

3. 4393055 - Hydroxyalkyl ether derivatives of rutin poly(H-)sulfate and method of use (1983-07-12),

4. 4359461 - Mono-, di- and tri-adamantylcarbonyl- digalactopyranosyl- (1982-11-16),

5. 4359460 - 6'-(1-Adamanta (1982-11-16),

6. 4359459 - O-.alpha.-D-Multigalactopyranosyl-O-.alpha.-D-multiglucopyranosyl-O-.beta.- (1982-11-16),

7. 4359458 - O-.beta.. -D (and O-.alpha... -D) Multigalactopyranosyl, xylopyranosyl (1982-11-16),

8. 4357326 - Multi-glucopyranosyl-fructofuranosyl-galactopyranosyl-glucopyranoside (1982-11-02),

9. 4342753 - Carboxyalkyl derivatives of rutin poly(H-)sulfate (1982-08-03),

10. 4342752 - Carbalkoxymethyl derivatives of rutin poly(H-)sulfate and method of use (1982-08-03),

11. 4334058 - Rutin poly(H--)sulfate salts and related compounds (1982-06-08),

12. 4304904 - D-Erythro-2,3-dihydroxy-1-(and 3-) (1981-12-07),

13. 4304903 - D-Erythro-2,3-dihydroxy-1-(1-phenyl-1H-pyrazolo(3,4-b)quinoxalin-3-y (1981-12-08),

14. 4232150 - Oligosaccharide precursors to substituted O-.alpha.-D and (1980-11-04),

15. 4221907 - Substituted O-.alpha.-D and O-.beta.-D-multi-galactopyranosyl and (1980-09-09),

Title: Innovations and Contributions of Vijay G Nair

Introduction

Vijay G Nair is a prominent inventor based in New York, NY, whose extensive work has resulted in a remarkable portfolio of 21 patents. His innovations focus primarily on novel compounds that have significant implications in the field of medicine, particularly in immune response modulation.

Latest Patents

Among his latest patents, one notable invention is the development of substituted dibenzothiophenes. This patent describes novel derivatives of dibenzothiophene, including dibenzothiophene sulfoxide, dibenzothiophene sulfone, thioxanthene, thioxanthene sulfoxide, and thioxanthene sulfone, which serve as modulators of the mammalian immune response system. Another significant patent involves rutin poly(H-)sulfate salts and related compounds, which are useful as complement inhibitors in therapeutic applications.

Career Highlights

Vijay G Nair's contributions to the field are primarily achieved through his work at American Cyanamid Company, where he has been able to translate his innovative ideas into patented technologies that enhance medical research and treatment options.

Collaborations

Throughout his career, Vijay has collaborated with esteemed colleagues including Seymour Bernstein and Joseph P Joseph. These collaborations have enriched his research efforts and contributed to the success of his patented inventions.

Conclusion

Vijay G Nair's dedication to innovation is evidenced by his impressive patent portfolio and his commitment to advancing medical science. His work continues to influence the development of new therapeutic agents, showcasing the critical role of inventors in fostering innovation and improving healthcare outcomes.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]